Gaudium IVF touches roof on unveiling AI Powered Signature Labs in South Delhi
Gaudium IVF and Women Health is currently trading at its upper circuit limit of Rs. 143.55, up by 6.80 points or 4.97% from its previous closing of Rs. 136.75 on the BSE.
The scrip opened at Rs. 139.40 and has touched a high and low of Rs. 143.55 and Rs. 138.75 respectively. So far 6531 shares were traded on the counter.
The BSE group 'T' stock of face value Rs. 5 has touched a 52 week high of Rs. 143.55 on 17-Jul-2026 and a 52 week low of Rs. 69.50 on 23-Mar-2026.
Last one week high and low of the scrip stood at Rs. 143.55 and Rs. 120.10 respectively. The current market cap of the company is Rs. 1044.86 crore.
The promoters holding in the company stood at 71.29%, while Institutions and Non-Institutions held 5.24% and 23.47% respectively.
Gaudium IVF and Women Health has unveiled AI Powered Signature Labs in South Delhi, kicking off its first milestone in the company's planned 19-centre expansion, as outlined in the growth roadmap shared with investors during its IPO. The launch reinforces the company's commitment to making high quality, technology driven fertility care more accessible to aspiring parents through a standardised clinical and laboratory model that combines AI powered innovation with the highest standards of clinical excellence, patient safety and ethical care.
The new centre offers comprehensive fertility care under one roof, combining experienced fertility specialists, advanced reproductive medicine and Gaudium IVF's standardised clinical protocols. At the heart of the new centre is the Gaudium Signature Lab, the company's proprietary laboratory framework that integrates advanced embryology, AI-powered technologies and internationally benchmarked quality standards to create an optimal environment for embryo development. As Gaudium IVF expands its network, the Signature Lab model will be replicated across every new centre, ensuring patients experience the same high standards of precision, safety and clinical excellence, irrespective of location.
The centre also brings together Gaudium IVF's AI-powered embryology ecosystem, including SiD (Sperm Identification Device) for advanced sperm assessment and ERICA (Embryo Ranking Intelligent Classification Assistant) for embryo evaluation. By complementing the expertise of embryologists with data-driven insights, these technologies enhance precision, consistency and confidence throughout the IVF journey.
